Kalbe Farma Prepares Initiatives for 2026 Business Growth

Positive Outlook Despite External Challenges

PT Kalbe Farma Tbk (KLBF) is optimistic about its business prospects for 2026, despite the presence of external challenges. The company's Head of External & Stakeholders Relation, Hari Nugroho, stated that Kalbe will continue to target sustainable growth by leveraging its performance in the prescription drugs, health products, nutrition, and distribution and logistics segments.

Focus on Innovation and Strategic Partnerships

According to Hari Nugroho, Kalbe will focus on innovation and strategic partnerships to capture long-term growth opportunities. The company believes that its initiatives and strategies will enable it to achieve positive growth in 2026.

Business Segments and Growth Strategies

Kalbe's business segments, including prescription drugs, health products, nutrition, and distribution and logistics, are expected to contribute to the company's growth in 2026. The company will continue to invest in research and development to enhance its product portfolio and improve its competitiveness in the market.